Cargando…
The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts
In the last decade, osteopontin (OPN) was identified as one of the important proteins that promote the metastasis of tumor. However, the association between OPN overexpression and clinical outcome of non-small-cell lung cancer (NSCLC) was unclear. The purpose of this study is to investigate the role...
Autores principales: | Wang, Ying, Yang, Jin, Liu, Hui, Bi, Ji-Rui, Liu, Ying, Chen, Yan-Yan, Cao, Ji-Yu, Lu, You-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664515/ https://www.ncbi.nlm.nih.gov/pubmed/26648743 http://dx.doi.org/10.2147/OTT.S94082 |
Ejemplares similares
-
Osteopontin genetic variants are associated with overall survival in advanced non-small-cell lung cancer patients and bone metastasis
por: Chen, Yunzhen, et al.
Publicado: (2013) -
Osteopontin is a prognostic biomarker in non-small cell lung cancer
por: Rud, Ane Kongsgaard, et al.
Publicado: (2013) -
Plasma Osteopontin Is a Useful Diagnostic Biomarker for Advanced Non-Small Cell Lung Cancer
por: Han, Seon-Sook, et al.
Publicado: (2013) -
Overexpression of Osteopontin, αvβ3 and Pim-1 Associated with Prognostically Important Clinicopathologic Variables in Non-Small Cell Lung Cancer
por: Jin, Yi, et al.
Publicado: (2012) -
Inhibition of osteopontin overcomes acquired resistance to afatinib in EGFR-mutant non-small-cell lung cancer
por: Zhang, Hongye, et al.
Publicado: (2020)